Skip to main content

Table 7 Percent ocular pain free (ITT)

From: Phase II placebo-controlled study of nepafenac ophthalmic suspension 0.1% for postoperative inflammation and ocular pain associated with cataract surgery in Japanese patients

Treatment

Total

Pain free

N

N

%

Nepafenac group

106

102

96.2

Placebo group

105

71

67.6

  1. Test = Chi-square, P < 0.0001